Pluri Inc (PLUR) Stock Price, Quote & News

Company Profile

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. The company's product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatme...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 74 710 8600

Website: www.pluri-biotech.com

Address:

MATAM Advanced Technology Park, Building No. 5, Haifa, Israel

GiftGuru Dec. 26 at 8:56 AM

$PLUR Sentiment here is shifting toward proof-driven evaluation rather than narrative enthusiasm. Strategic direction should avoid unnecessary detours. Improved transparency could compress valuation discounts. The outlook strengthens only as evidence accumulates.

0 · Reply

FirmFocus Dec. 25 at 5:44 PM

$PLUR This ticker is entering a stage where execution quality will overshadow headline narratives. Management alignment and prioritization play a larger role from here. Investors are likely to reward clarity more than ambition. In short, this remains an execution‑driven story with meaningful but conditional upside.

0 · Reply

PLURI_JUGGERNAUT_ Dec. 22 at 11:00 PM

$PLUR Kokomodo/Coffeesai The Cultured Hub unveils plant cell culturing for cocoa, coffee, and other ingredients https://www.comunicaffe.com/the-cultured-hub-unveils-plant-cell-culturing-for-cocoa-coffee-and-other-ingredients/

0 · Reply

prismmarketview Dec. 22 at 4:47 PM

Pluri (NASDAQ: $PLUR)and Remedy Cell have expanded their CDMO partnership after successfully transferring Remedy Cell’s RC‑0315 manufacturing process into Pluri’s GMP facility, completing engineering runs and producing multiple clinical‑grade batches that will supply RC‑0315’s first Phase 1b trial in idiopathic pulmonary fibrosis. https://prismmarketview.com/pluri-and-remedy-cell-expand-partnership-reach-clinical-grade-manufacturing-milestone/

0 · Reply

JohnTrack Dec. 22 at 2:50 PM

$PLUR Expand Collaboration https://www.rapidticker.com/news/plur-pluri-and-remedy-cell-expand-30b064

0 · Reply

StockScanners Dec. 20 at 6:25 PM

$PLUR reached 3.62

0 · Reply

BestNwest Dec. 20 at 1:34 PM

$PLUR potential

0 · Reply

StockScanners Dec. 19 at 5:06 AM

$PLUR keep watch if this holds above 3.28

0 · Reply

BestNwest Dec. 18 at 7:05 PM

$PLUR look like a little merger with some partnerships

2 · Reply

Bumbleclod Dec. 12 at 4:17 AM

$PLUR Headed for the Pink sheets........LOL

0 · Reply

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

May 27, 2025, 7:00 AM EDT - 7 months ago

BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn® Phase 3b ALS Clinical Trials

Apr 28, 2025, 8:00 AM EDT - 8 months ago

Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd.

Mar 5, 2025, 7:00 AM EST - 10 months ago

Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness

Feb 19, 2025, 9:01 AM EST - 11 months ago

Ever After Foods and Bühler Collaborate to Scale Cultivated Meat Production and Distribution

Jan 23, 2025, 7:15 AM EST - 1 year ago

Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition

$Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease$

Dec 19, 2024, 8:00 AM EST - 1 year ago

Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease

Nov 12, 2024, 1:00 PM EST - 1 year ago

Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event

Nov 11, 2024, 6:00 AM EST - 1 year ago

BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing

Jul 18, 2024, 2:30 AM EDT - 1 year ago

Pluri's CDMO Selected to Manufacture Kadimastem's Novel Cell Therapy Product Candidates

Jun 18, 2024, 12:45 PM EDT - 1 year ago

Pluri: Biotech Play With Several Opportunities Across Different Sectors

Jun 18, 2024, 6:30 AM EDT - 1 year ago

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges

Jun 6, 2024, 6:45 AM EDT - 1 year ago

U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri's PLX-R18 Acute Radiation Syndrome Contract

May 20, 2024, 7:00 AM EDT - 1 year ago

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

May 2, 2024, 7:00 AM EDT - 1 year ago

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

Apr 8, 2024, 7:00 AM EDT - 1 year ago

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

Mar 28, 2024, 7:15 AM EDT - 1 year ago

Pluri's Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

Mar 27, 2024, 7:00 AM EDT - 1 year ago

Pluri Inc. Announces 1-for-8 Reverse Share Split

Mar 21, 2024, 7:00 AM EDT - 1 year ago

Pluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

Mar 19, 2024, 4:00 AM EDT - 1 year ago

Engage with Pluri's Talent: Exciting Conference Appearances Ahead

Mar 14, 2024, 7:00 AM EDT - 1 year ago

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

Mar 11, 2024, 7:00 AM EDT - 1 year ago

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

Mar 6, 2024, 7:00 AM EST - 1 year ago

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

Feb 28, 2024, 7:00 AM EST - 1 year ago

Pluri's Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

Jan 23, 2024, 2:00 AM EST - 2 years ago

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

Jan 8, 2024, 7:00 AM EST - 2 years ago

Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Pluri's PLX-R18 Increases Blood Cell Counts and Reduces Need for Transfusions in a Phase I Study: Results Published in Nature Bone Marrow Transplantation

Jul 13, 2023, 2:00 AM EDT - 2 years ago

Pluri Announces Appointment of Entrepreneur Lorne Abony to Board of Directors

Jul 11, 2023, 2:00 AM EDT - 2 years ago

U.S. National Institutes of Health to Fund $4.2 Million Contract to Advance Development of Pluri's PLX-R18 in Conjunction with U.S. DoD as a Medical Countermeasure for Hematopoietic Acute Radiation Syndrome

Apr 27, 2023, 7:00 AM EDT - 2 years ago

Cell Manufacturing Pioneer, Pluri Inc., Unveils PluriMatrix: a Breakthrough System for Unprecedented Industrial Scale Production of Cell-Based Products

Mar 13, 2023, 8:00 AM EDT - 3 years ago

Israel's Ministry of Labor Names Pluri as Winner of the 2022 Egalitarian Employment Award for its Commitment to Gender Diversity and Pay Equity

Dec 22, 2022, 7:00 AM EST - 3 years ago

Pluri CEO Issues Letter to Shareholders Summarizing the Strategy Change and Progress in 2022 and Announcing Food Tech Joint Venture Proof of Concept

Dec 15, 2022, 4:05 PM EST - 3 years ago

Pluri Prices $8.2 million Private Placement Offerings Priced At-The-Market Under Nasdaq Rules

Nov 10, 2022, 7:00 AM EST - 3 years ago

Pluri wins BioTech Breakthrough Cell Innovation of the Year Award

Oct 31, 2022, 8:00 AM EDT - 3 years ago

Pluri to Present and Participate in Upcoming Conferences

Sep 29, 2022, 7:00 AM EDT - 3 years ago

Pluri CEO Issues Letter to Shareholders Announcing New Tech Collaboration, Cost Reduction in line with New Strategy and Financial Updates

Sep 6, 2022, 7:00 AM EDT - 3 years ago

€7.5 Million Granted to Collaborative PROTO Project led by Charité to Study Pluri's PLX-PAD Cells for Osteoarthritis Treatment

Jul 25, 2022, 7:00 AM EDT - 3 years ago

Pluri CEO Issues Shareholder Update

Jul 25, 2022, 1:00 AM EDT - 3 years ago

Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company's Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional Industries

Jul 13, 2022, 9:59 AM EDT - 3 years ago

Pluristem Posts Mixed Results From Study Of Muscle Regeneration After Hip Fracture Surgery

Jul 13, 2022, 6:00 AM EDT - 3 years ago

Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery

Mar 28, 2022, 3:00 AM EDT - 4 years ago

Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New Partnership

Mar 23, 2022, 7:30 AM EDT - 4 years ago

Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood Transfusions

Mar 8, 2022, 7:12 AM EST - 4 years ago

Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint Venture

Mar 2, 2022, 7:00 AM EST - 4 years ago

Pluristem CEO Issues Shareholder Update

Feb 24, 2022, 7:00 AM EST - 4 years ago

Pluristem Announce the Closing of its Collaboration with Tnuva Group to Establish Cultured Food Platform

Jan 10, 2022, 6:26 AM EST - 4 years ago

Biotech Pluristem, Israel-Based Tnuva Collaborate On Cultured Food Platform

Jan 10, 2022, 3:00 AM EST - 4 years ago

Biotechnology Company Pluristem, and Israel's Largest Food Producer Tnuva, Launch Landmark Collaboration to Establish Cultured Food Platform

Dec 27, 2021, 7:00 AM EST - 4 years ago

Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19

Nov 15, 2021, 7:10 AM EST - 4 years ago

Pluristem Completes Enrollment of Its Multinational Phase III Study of Muscle Regeneration Following Hip Fracture Surgery

GiftGuru Dec. 26 at 8:56 AM

0 · Reply

FirmFocus Dec. 25 at 5:44 PM

0 · Reply

PLURI_JUGGERNAUT_ Dec. 22 at 11:00 PM

0 · Reply

prismmarketview Dec. 22 at 4:47 PM

0 · Reply

JohnTrack Dec. 22 at 2:50 PM

$PLUR Expand Collaboration https://www.rapidticker.com/news/plur-pluri-and-remedy-cell-expand-30b064

0 · Reply

StockScanners Dec. 20 at 6:25 PM

$PLUR reached 3.62

0 · Reply

BestNwest Dec. 20 at 1:34 PM

$PLUR potential

0 · Reply

StockScanners Dec. 19 at 5:06 AM

$PLUR keep watch if this holds above 3.28

0 · Reply

BestNwest Dec. 18 at 7:05 PM

$PLUR look like a little merger with some partnerships

2 · Reply

Bumbleclod Dec. 12 at 4:17 AM

$PLUR Headed for the Pink sheets........LOL

0 · Reply

jlonards Dec. 9 at 3:26 AM

$PLUR active board

1 · Reply

PLURI_JUGGERNAUT_ Nov. 25 at 4:38 PM

$PLUR Development of PLX-R18, a promising and novel countermeasure for radiation-associated injuries. https://pubmed.ncbi.nlm.nih.gov/41083142/

0 · Reply

BillionerOfKing Nov. 20 at 2:30 PM

$PLUR Current Stock Price: $3.71

0 · Reply

PLURI_JUGGERNAUT_ Nov. 14 at 7:40 PM

$PLUR Kokomodo Partners With Coop Switzerland to Explore Integration of Cultivated Cacao Into Confectionery Halba is a Swiss chocolate manufacturer and a division of the Coop Group, which is a large Swiss retail, wholesale, and production company. Halba is one of the leading producers of sustainable Swiss chocolate, snacks, and baking ingredients, while the Coop Group has around 2,500 retail outlets in Switzerland and employs about 90,000 people. https://cultivated-x.com/company-news/kokomodo-partners-coop-switzerland-explore-integration-cultivated-cacao-confectionery/

0 · Reply

PLURI_JUGGERNAUT_ Nov. 13 at 1:46 PM

$PLUR Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year https://pluri-biotech.com/releases/pluri-and-subsidiaries-earn-multiple-industry-honors-named-as-overall-bioagriculture-company-of-the-year/

0 · Reply

PLURI_JUGGERNAUT_ Nov. 11 at 7:16 PM

$PLUR Giddy-Up !!! https://missuniverseskincare.com/pages/our-story

0 · Reply

PLURI_JUGGERNAUT_ Nov. 11 at 1:09 PM

$PLUR Pluri Press Release !!! Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare https://pluri-biotech.com/releases/pluri-partners-with-miss-universe-skincare-introducing-exosome-enhanced-regenerative-skincare/

0 · Reply